Skip to main content
Clinical Trials/NCT04176835
NCT04176835
Completed
Not Applicable

Neurobiological Effects of Oxytocin on Social Decision Making in Schizophrenia: A Pharmacological MRI Study

National Institute of Mental Health and Neuro Sciences, India0 sites55 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Oxytocin nasal spray
Conditions
Schizophrenia
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Enrollment
55
Primary Endpoint
fMRI changes with oxytocin while performing ultimatum game and at rest
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

schizophrenia patients and healthy volunteers will be included. Subjects who meet the inclusion and exclusion criteria for the study will be recruited. After completion of clinical assessments and neuropsychological assessments, all subjects will undergo two fMRI scans. In one scan subjects will receive a single dose of intranasal oxytocin and in another scan, they will receive intranasal saline. The order of administration of oxytocin or saline will be counterbalanced so that they are not administered in the same order to all subjects. Subjects will be blind to the drug administered.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
September 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Sponsor
National Institute of Mental Health and Neuro Sciences, India
Responsible Party
Principal Investigator
Principal Investigator

Dr Naren P Rao

Additional Professor of Psychiatry

National Institute of Mental Health and Neuro Sciences, India

Eligibility Criteria

Inclusion Criteria

  • Males between 18 and 45 years with at least 7 years of education
  • The DSM-IV diagnosis of Schizophrenia or schizoaffective or schizophreniform disorder
  • capacity to provide informed consent

Exclusion Criteria

  • Current comorbid DSM-IV axis I diagnosis
  • General impaired intellectual functioning
  • history of alcohol or substance abuse or dependence in the last 12 months
  • contraindication to Oxytocin like hypersensitivity, vascular disease, chronic nephritis, epilepsy, asthma
  • past history of head injury resulting in loss of consciousness or neurosurgery
  • concomitant severe medical conditions
  • metal implants or paramagnetic objects within the body or claustrophobia which may interfere with the MRI.
  • Healthy volunteers:
  • Inclusion Criteria:
  • Males between 18 and 45 years with at-least 7 years education

Arms & Interventions

oxytocin

Single-dose intranasal oxytocin or intranasal placebo administered in counterbalanced order

Intervention: Oxytocin nasal spray

Placebo

Single-dose intranasal oxytocin or intranasal placebo administered in counterbalanced order

Intervention: Placebo

Outcomes

Primary Outcomes

fMRI changes with oxytocin while performing ultimatum game and at rest

Time Frame: 90 minutes

Changes in brain activity and functional connectivity

Similar Trials